Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
‘Real life’ effectiviteit en veiligheid van SOF/VEL/VOX bij HCV na falen op DAA
nov 2019 | Hepatitis